| Similar Articles |
|---|
 |
Chemistry World
June 8, 2015
Maria Burke |
Warnings that proposed UK blanket ban on 'legal highs' casts net too wide Some legal experts and scientists are warning that a proposed blanket ban on so-called 'legal highs' won't tackle the problem and may well hold back research into areas such as neuroscience.   |
Chemistry World
June 24, 2015
Patrick Walter |
Legal in theory Governments around the world are faced with the particularly tricky problem of what they should do about 'legal highs'. |
Chemistry World
May 15, 2009
Katrina Megget |
Tripping over red tape The UK may be moving a step closer to allowing the use of a cannabis-based drug to treat the symptoms of multiple sclerosis |
Chemistry World
June 4, 2013
Maria Burke |
'Legal high' production gathers pace New designer drugs are popping up in Europe at an unprecedented rate, sometimes on the illicit drug market and sometimes as 'legal' alternatives to controlled drugs, according to the latest report by the EU drugs agency. |
Chemistry World
January 6, 2014
Mark Peplow |
The morning after the night before David Nutt, a neuropsychopharmacologist at Imperial College London, has an idea with obvious appeal: an alcohol substitute that promises all of the fun of bacchic revelry without the throbbing head and washing-machine stomach that follow. |
Chemistry World
November 6, 2009
Anna Lewcock |
Loss of senior chemist throws further doubt on future of UK drugs council David Nutt has insisted he has 'right on his side' following his unceremonious dismissal as chair of the UK Home Office Advisory Council on the Misuse of Drugs. |
AskMen.com
March 18, 2015
Gonzo Nieto |
The Health Benefits Of Psychedelic Drugs As weed becomes more accepted, are psychedelic drugs next? Here's why you should take LSD seriously. |
Chemistry World
June 26, 2013
Emma Stoye |
UN report warns of global rise in legal highs The latest World Drug Report from the United Nations Office on Drugs and Crime says governments around the world are struggling to cope with a growing number of legal party drugs. |
Chemistry World
May 9, 2011
Sarah Houlton |
Ecstasy substitute poses major health risks Scientists at Anglia Ruskin University haves shown that one of the most common 'legal high' designer drugs, benzylpiperazine, is not only dangerous when it's taken - repeated consumption poses major health risks. |
Chemistry World
May 29, 2015
Emma Stoye |
UK launches universal ban on legal highs New laws banning the sale and distribution of all legal highs -- or new psychoactive substances -- have been drafted by the UK government. |
Chemistry World
February 17, 2015
Rebecca Trager |
Clinical trials high on list for medical marijuana community The drug's controlled status is continuing to slow efforts to investigate the myriad compounds in the plant. |
Chemistry World
April 9, 2013
Emma Stoye |
Drug restrictions delay magic mushroom trial The first clinical trial to explore the antidepressant effects of psilocybin, the hallucinogenic component of magic mushrooms, has been delayed by EU and UK drug regulations. |
Chemistry World
January 11, 2012
Hayley Birch |
Drive towards detecting drugs at the roadside The UK government is setting up an advisory panel that will assess the feasibility of roadside testing for drug driving, similar to testing for drunk driving. |
American Family Physician
March 15, 2004 |
Substance Abuse Questions and answers on substance abuse. |
Chemistry World
April 30, 2014
Emma Stoye |
New Zealand in legal highs U-turn Politicians in New Zealand have decided to ban designer drugs from sale in the country, reversing an earlier decision to approve low risk drugs while new laws are put in place. |
Chemistry World
July 9, 2015
Maria Burke |
UK 'legal highs' bill under fire from scientific community Calls are growing from the scientific community for home secretary Theresa May to amend the psychoactive substances bill. |
Salon.com
September 12, 2002
Sheerly Avni |
Ecstasy begets empathy Psychiatrist and drug researcher Dr. Charles Grob sees value in MDMA -- when it's taken in therapy, not at a rave. |
Reason
June 2005
Jacob Sullum |
Psychedelic Revival Psychedelic research is returning to Harvard, where psychiatrist John Halpern plans to give MDMA (a.k.a. Ecstasy) to late-stage cancer patients to relieve their anxiety and to help them come to terms with death. |
Chemistry World
March 23, 2010 |
Comment: Can we halt the flow of new designer drugs? Could the dangers of 'legal high' mephedrone have been predicted? Of course they could, says John Mann |
Chemistry World
March 29, 2010
Anna Lewcock |
Drug adviser quits over science advice rules The resignation of a sixth scientist from the UK government's drugs advisory body could trigger more departures and calls into further question the council's ability to offer vital scientific advice. |
Chemistry World
June 3, 2015
Katrina Kramer |
Drugged: the science and culture behind psychotropic drugs Richard Miller, a pharmacology researcher at Northwestern University, US, and a medical humanities and bioethics professor, has written his first popular science book on the chemistry and culture of psychoactive compounds. |
Chemistry World
November 11, 2009
Anna Lewcock |
Three more scientists quit drugs council Three more members of the UK government's drugs advisory council have resigned, including renowned chemist Simon Campbell. |
Pharmaceutical Executive
September 1, 2005
Parker & Amar |
Building Blockbusters The most lucrative new drugs are often less glamorous than first-in-class new molecular entities. And they are much less risky. |
ifeminists
November 17, 2004
Byron Fraser |
Review: Your Drug May Be Your Problem Excerpts from the book Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Medications by Peter Breggin and David Cohen delineating the adverse effects of these medications and how to stop taking them. |
Chemistry World
June 11, 2014
Mark Peplow |
A mind-blowing legacy For some, Alexander Shulgin was a bold explorer at the frontiers of neurochemistry. To others, he was the wanton architect of a wave of dangerous recreational drugs: the godfather of ecstasy. |
Salon.com
August 4, 2000
Gary Kamiya |
Writing high In "Writing on Drugs," Sadie Plant embarks on a stimulating trip into literature's strangest, smokiest den. |
Pharmaceutical Executive
July 1, 2005
Patrick Clinton |
Playing Doctor Why Congress plans to ban erectile dysfunction drugs from Medicare and Medicaid, and why they shouldn't do it. |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
Chemistry World
June 2011 |
Breaking through the barrier Getting drug molecules into the brain means crossing the defensive blood-brain barrier. Anthony King investigates how chemists are infiltrating the brain's fortress |
American Family Physician
June 1, 2004 |
Club Drugs-Myths and Risks This article provides a general overview on the topic of club drugs like Ecstasy. |
Reason
October 2004
Michael Erard |
Open Secrets How the U.S. government lost the drug war in cyberspace. |
Reason
April 2002
Jacob Sullum |
Pot Stops In the United States, it's clearly not true that no one gets arrested for smoking pot anymore. But it looks like that will soon be the case in Britain, home of Europe's harshest drug laws... |
Salon.com
July 16, 2002
Greg Harrison |
Lawmakers addicted to the quick fix Drug legislation like the proposed RAVE Act does more to promote illicit drug use than discourage it. |
Chemistry World
October 1, 2007
Victoria Gill |
Anorexia Shares Addictive Pathway with Ecstasy Researchers in France have discovered that anorexia and MDMA share a common signaling pathway in the brain - both reducing the drive to eat by stimulating the same subset of receptors for the neurotransmitter serotonin. |
Pharmaceutical Executive
October 1, 2011
Jill Wechsler |
At the Helm of Industry As the lead FDA official overseeing the testing and approval of new drugs and biotech therapies for some 20 years, Dr. Janet Woodcock has built a robust and modern drug regulatory system. |
Salon.com
June 21, 2000
Kuhn & Wilson |
Dazed and unused In the debut of a new column on drugs, our expert pharmacologists advise a woman on what to do with her stoned boyfriend's lack of interest in sex. |
Reason
January 2002
Jacob Sullum |
Sex, Drugs, and Techno Music Why the rap against Ecstasy has a familiar ring to it |
Chemistry World
February 3, 2015 |
High hopes The multi-target, rebalancing properties of cannabinoids also explains why they show promise as drugs in such a wide variety of conditions. |
Chemistry World
January 17, 2008
Lewis Brindley |
Nanomachines to Treat Cancer Scientists at the University of California-Los Angeles (UCLA) have signed a deal with a private investment firm to develop and market 'nanomachines' to treat cancer. |
Chemistry World
October 8, 2010
Sarah Houlton |
U-turn on Alzheimer's drugs in the UK The UK National Institute for Health and Clinical Excellence proposes that those with mild disease will be able to receive them from early next year, on the basis of growing clinical evidence of their effectiveness. |
Salon.com
September 1, 2000
Eric Sabo |
Chemical ravings Worried that ecstasy may fry the serotonin cells in their brains, some ravers are taking Prozac. |
AskMen.com
Dave Golokhov |
Smart Drugs Research found in Current Directions in Psychological Science indicates that there's a limit on how smart one person can get -- no matter how much you train their brain and regardless of what type of brain-boosting drugs are on the way. |
American Family Physician
June 1, 2004
Gahlinger |
Club Drugs: MDMA, Gamma-Hydroxybutyrate (GHB), Rohypnol, and Ketamine About club drugs, outcomes of ingestion and treatments after ingestion. |
Salon.com
August 9, 2000
Cynthia Kuhn & Wilkie Wilson |
Medicinal muse Can one become more creative by doing drugs? |
The Motley Fool
November 7, 2008
Brian Orelli |
Thinning Out the Pipeline The FDA says no to diet drugs from Sanofi-Aventis and Pfizer. |
The Motley Fool
June 6, 2006
Brian Lawler |
Exelixis' Continued Excellence The company reported preliminary phase 1 results for three of its lead compounds. Until investors see the results from phase 2 trials, they should chalk Exelixis up as a promising young biotech company whose successes they will patiently cheer for from the sidelines. |
Chemistry World
December 2009 |
Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs |
Chemistry World
March 27, 2013
Eugene Gerden |
Russian investment vehicle sets sights on innovative drugs Russian state-owned nanotechnology giant Rusnano is hoping to break into the pharmaceutical sector with sizeable investments in firms seeking to produce innovative drugs. |
Reason
April 2007
Jacob Sullum |
Data: America's Biggest Cash Crop According to a conservative think tank, agricultural price supports cost American consumers about $27 billion a year by making food more expensive. But that figure omits the government's biggest price support program: the war on drugs. |
Pharmaceutical Executive
January 1, 2007
Glass & Poli |
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. |
